Header Logo

Connection

Chundo Oh to Mesoderm

This is a "connection" page, showing publications Chundo Oh has written about Mesoderm.
Connection Strength

0.455
  1. Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. J Biol Chem. 2000 Feb 25; 275(8):5613-9.
    View in: PubMed
    Score: 0.184
  2. Retinoic acid inhibits chondrogenesis of mesenchymal cells by sustaining expression of N-cadherin and its associated proteins. J Cell Biochem. 2003 Jul 01; 89(4):837-47.
    View in: PubMed
    Score: 0.058
  3. Immunosuppressant rapamycin inhibits protein kinase C alpha and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis. Eur J Pharmacol. 2001 Sep 21; 427(3):175-85.
    View in: PubMed
    Score: 0.051
  4. Protein kinase A regulates chondrogenesis of mesenchymal cells at the post-precartilage condensation stage via protein kinase C-alpha signaling. J Bone Miner Res. 2000 Nov; 15(11):2197-205.
    View in: PubMed
    Score: 0.048
  5. Epidermal growth factor negatively regulates chondrogenesis of mesenchymal cells by modulating the protein kinase C-alpha, Erk-1, and p38 MAPK signaling pathways. J Biol Chem. 2000 Apr 21; 275(16):12353-9.
    View in: PubMed
    Score: 0.046
  6. Protein kinase C regulates chondrogenesis of mesenchymes via mitogen-activated protein kinase signaling. J Biol Chem. 1998 Jul 24; 273(30):19213-9.
    View in: PubMed
    Score: 0.041
  7. Regulation of the chondrocyte phenotype by beta-catenin. Development. 2002 Dec; 129(23):5541-50.
    View in: PubMed
    Score: 0.014
  8. Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal-regulated protein kinase. J Biol Chem. 2002 Mar 08; 277(10):8412-20.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.